Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001654954-23-000197
Filing Date
2023-01-06
Accepted
2023-01-06 16:30:31
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tenx_sc13da.htm SC 13D/A 29037
  Complete submission text file 0001654954-23-000197.txt   30652
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Subject) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-58467 | Film No.: 23515460
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOHAVEN PHARMACEUTICAL HOLDING COMP 234 CHURCH STREET NEW HAVEN CT 06510
Business Address
Doogan Declan (Filed by) CIK: 0001704234 (see all company filings)

Type: SC 13D/A